Pancreatic Cancer Therapeutics And Diagnostic Is Estimated To...

added article Health

2023-11-30 12:15:46 -

Pancreatic Cancer Therapeutics And Diagnostic Is Estimated To Witness High Growth Owing To Rising Incidence Of Pancreatic Cancer

Market Dynamics: The pancreatic cancer therapeutics and diagnostic market is primarily driven by rising incidence of pancreatic cancer globally. According to the National Cancer Institute, it is estimated that around 60,430 Americans will be diagnosed with pancreatic cancer in 2022. Other key drivers include growing geriatric population, increasing adoption of imaging modalities for diagnosis...

0 Comments 0 Shares 894 Views 0 Reviews